• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AMC Health, Glooko Partner to Deliver BYOD Solution To Patients With Diabetes

by HITC Staff 07/11/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AMC Health, Glooko Partner to Deliver BYOD Solution To Patients With Diabetes

AMC Health, a provider of proven remote patient monitoring and engagement solutions and Glooko Inc., a population health platform for diabetes management has announced a partnership to help clinicians and patients improve diabetes outcomes at lower costs.

Glooko is one of many FDA 510(k) cleared devices now integrated into AMC Health’s expanding FDA-cleared CareConsole® virtual care platform. Glooko is currently being used in 1,000+ health systems, health plans and employers in the USA, including Joslin Diabetes Center, Stanford Health, and Atrius Health in Boston.

Adding Glooko to the AMC Health CareConsole® platform with robust decision support analytics provides healthcare organizations tools to better optimize their clinical impact in diabetes populations. Glooko’s HIPAA-compliant solution enables easy downloading of information from over 50 of the most popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs). Glooko enables individuals to download and add context to their data through its award-winning diabetes mobile app .

“Glooko will be joining AMC Health’s extensive ecosystem of healthcare technology partners that have chosen to integrate into AMC Health’s CareConsole® virtual care platform. This partnership with Glooko will give patients the flexibility of using their existing glucometers and support stronger connections with their clinical teams on a real-time basis, while also expanding care beyond the walls of hospitals, doctors’ offices and outpatient settings,” said Nesim Bildirici, founder and CEO of AMC Health. “Our clinically proven solutions, and clinical, technology and analytics expertise, gained over millions of patient days, ensure that our solutions promote patient engagement, improve patient outcomes, and prevent costly acute episodes.”

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AMC Health, diabetes app, Diabetes Management, Glooko

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |